{{Rsnum
|rsid=1412259
|Chromosome=9
|position=1456797
|Orientation=minus
|GMAF=0.3343
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 17.7 | 42.5 | 39.8
| HCB | 2.2 | 29.9 | 67.9
| JPT | 5.3 | 32.7 | 61.9
| YRI | 12.2 | 44.2 | 43.5
| ASW | 12.3 | 38.6 | 49.1
| CHB | 2.2 | 29.9 | 67.9
| CHD | 1.8 | 30.3 | 67.9
| GIH | 9.9 | 53.5 | 36.6
| LWK | 11.8 | 40.9 | 47.3
| MEX | 12.1 | 37.9 | 50.0
| MKK | 13.5 | 47.7 | 38.7
| TSI | 24.5 | 48.0 | 27.5
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (docetaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=4E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}